KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abbott Laboratories (ABT) Return on Invested Capital (2016 - 2025)

Abbott Laboratories' Return on Invested Capital history spans 17 years, with the latest figure at 0.1% for Q4 2025.

  • For Q4 2025, Return on Invested Capital fell 34.0% year-over-year to 0.1%; the TTM value through Dec 2025 reached 0.1%, down 34.0%, while the annual FY2025 figure was 0.1%, 24.0% down from the prior year.
  • Return on Invested Capital for Q4 2025 was 0.1% at Abbott Laboratories, down from 0.37% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 1.33% in Q2 2025 and bottomed at 1.88% in Q3 2022.
  • The 5-year median for Return on Invested Capital is 0.4% (2024), against an average of 0.08%.
  • The largest annual shift saw Return on Invested Capital crashed -333bps in 2021 before it surged 239bps in 2023.
  • A 5-year view of Return on Invested Capital shows it stood at 0.45% in 2021, then plummeted by -512bps to 1.86% in 2022, then skyrocketed by 128bps to 0.53% in 2023, then fell by -18bps to 0.43% in 2024, then crashed by -78bps to 0.1% in 2025.
  • Per Business Quant, the three most recent readings for ABT's Return on Invested Capital are 0.1% (Q4 2025), 0.37% (Q3 2025), and 1.33% (Q2 2025).